Trials / Completed
CompletedNCT02178137
Effect of Interventions on the Progression of Knee Osteoarthritis
Effect of Interventions on Progression of Knee Osteoarthritis - a Comparison of Effect of Glucosamine/Chondroitin or Diacerin Vs Placebo: Measured by Clinical, Radiological and Biochemical Parameters
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 322 (actual)
- Sponsor
- Indus Hospital and Health Network · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
There has been intensive search for a substance that can have disease-modifying activity for osteoarthritis. A number of medications have been reported to be of benefit on slowing progression of knee OA. This trial will be the first head to head comparison of these medications. Patients aged between age 40 to 65 will be enrolled. Patients will be assessed clinically using two scoring systems, the WOMAC index for knee arthritis and the SF 36 for overall physical and mental health. The knee X rays will be assessed on Kellgren and Lawrence grading and will also be measured for joint space narrowing at follow up. The response to arthritis medications on slowing down cartilage loss will be measured biochemically with COMP levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diacerien | |
| DRUG | Glucosamine/Chondroitin | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2017-09-01
- Completion
- 2017-10-01
- First posted
- 2014-06-30
- Last updated
- 2018-03-01
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT02178137. Inclusion in this directory is not an endorsement.